Skip to main content
OpenTrials

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

455 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Completed

An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

NCT00930553

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • HOPE Research Institute Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center Barrow Neurology Clinics - Barrow Neurological Institute Phoenix, Arizona, United States
  • Mayo Clinic Arizona (Scottsdale) Scottsdale, Arizona, United States
View all 176 locations
View Trial Details
Completed

Gastrointestinal Tolerability Study Of Dimethyl Fumarate In Participants With Relapsing-Remitting Multiple Sclerosis In Germany

NCT02125604

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Augsburg, Germany
  • Research Site Bamburg, Germany
  • Research Site Bayreuth, Germany
  • Research Site Berlin, Germany
View all 19 locations
View Trial Details
Completed

Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two

NCT00548405

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations
  • North Central Neurology Associates, P.C. Cullman, Alabama, United States
  • Barrow Neurological Institute, St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Hope Research Institute Phoenix, Arizona, United States
  • Mayo Clinic Arizona, Department of Neurology Scottsdale, Arizona, United States
View all 191 locations
View Trial Details
Completed

BG00012 Phase 2 Combination Study in Participants With Multiple Sclerosis

NCT01156311

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Danbury, Connecticut, United States
  • Research Site Atlanta, Georgia, United States
View all 16 locations
View Trial Details
Completed

A Prospective, Open-label, Non-randomized, Clinical Trial to Determine if Natalizumab (Tysabri®) Improves Ambulatory Measures in Relapsing-remitting Multiple Sclerosis (RRMS) Patients

NCT00871780

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
Locations
  • Biogen Idec Investigative Site Liège, Belgium
  • Biogen Idec Investigative Site Puebla City, Mexico
  • Biogen Idec Investigative Site Bialystok, Poland
  • Biogen Idec Investigative Site Bydgoszcz, Poland
View all 15 locations
View Trial Details

Related conditions